173 related articles for article (PubMed ID: 37586167)
41. Generation and characterization of human induced pluripotent stem cell line METUi001-A from a 25-year-old male patient with relapsing-remitting multiple sclerosis.
Begentas OC; Koc D; Yurtogullari S; Temel M; Akcali KC; Demirkaya S; Kiris E
Stem Cell Res; 2021 May; 53():102370. PubMed ID: 34087999
[TBL] [Abstract][Full Text] [Related]
42. Generation of induced pluripotent stem cell line (XWHNi002-A) from a female with APP gene mutation.
Sun W; Wang P; Gong J; Chen Y; Yang Y; Luan H; Li S; Li R; Wei C
Stem Cell Res; 2023 Sep; 71():103149. PubMed ID: 37356183
[TBL] [Abstract][Full Text] [Related]
43. Generation of an induced pluripotent stem cell line (SYSUi005-A) from a patient with hypertrophic cardiomyopathy.
Zhang C; Shi J; Zhang Z; Zhao Q; Xie M; Chen Y; Xiang Q
Stem Cell Res; 2022 Jan; 58():102626. PubMed ID: 34942479
[TBL] [Abstract][Full Text] [Related]
44. Generation of the integration-free induced pluripotent stem cell line (FHUSTCi001-A) from a patient with glomerulopathy with fibronectin deposits harboring FN1 mutation.
Yu X; Wang H; Xiao F; Jiang S; Li K; Chen Q; Wang G; Kong F; Zhao S
Stem Cell Res; 2022 May; 61():102751. PubMed ID: 35395622
[TBL] [Abstract][Full Text] [Related]
45. Function and Immunogenicity of Gene-corrected iPSC-derived Hepatocyte-Like Cells in Restoring Low Density Lipoprotein Uptake in Homozygous Familial Hypercholesterolemia.
Okada H; Nakanishi C; Yoshida S; Shimojima M; Yokawa J; Mori M; Tada H; Yoshimuta T; Hayashi K; Yamano T; Hanayama R; Yamagishi M; Kawashiri MA
Sci Rep; 2019 Mar; 9(1):4695. PubMed ID: 30886174
[TBL] [Abstract][Full Text] [Related]
46. Generation of Patient-Specific induced Pluripotent Stem Cell from Peripheral Blood Mononuclear Cells by Sendai Reprogramming Vectors.
Quintana-Bustamante O; Segovia JC
Methods Mol Biol; 2016; 1353():1-11. PubMed ID: 25523810
[TBL] [Abstract][Full Text] [Related]
47. Generation of an induced pluripotent stem cell line, ICGi014-A, by reprogramming peripheral blood mononuclear cells from a patient with homozygous D90A mutation in SOD1 causing Amyotrophic lateral sclerosis.
Ustyantseva EI; Medvedev SP; Vetchinova AS; Illarioshkin SN; Leonov SV; Zakian SM
Stem Cell Res; 2020 Jan; 42():101675. PubMed ID: 31830646
[TBL] [Abstract][Full Text] [Related]
48. Generation and characterization of an induced pluripotent stem cell (iPSC) line from a patient with clozapine-resistant Schizophrenia.
Marsoner F; Marcatili M; Karnavas T; Bottai D; D'Agostino A; Scarone S; Conti L
Stem Cell Res; 2016 Nov; 17(3):661-664. PubMed ID: 27934603
[TBL] [Abstract][Full Text] [Related]
49. Generation and characterization of induced pluripotent stem cells from breast cancer patients carrying ATM mutations.
Zhang M; Venkateshappa R; Li A; Fowler MB; Telli ML; Wu JC
Stem Cell Res; 2023 Dec; 73():103246. PubMed ID: 37951143
[TBL] [Abstract][Full Text] [Related]
50. Generation of four patient-specific pluripotent induced stem cell lines from two Brazilian patients with amyotrophic lateral sclerosis and two healthy subjects.
Gubert F; Vasques JF; Cozendey TD; Domizi P; Toledo MF; Kasai-Brunswick TH; Loureiro MPS; Lima JMB; Gress CH; Cabello GMK; Cabello PH; Borgonovo T; Vaz IM; Silva R; Mendez-Otero R
Stem Cell Res; 2019 May; 37():101448. PubMed ID: 31077962
[TBL] [Abstract][Full Text] [Related]
51. Generation of seven iPSC lines from peripheral blood mononuclear cells suitable to investigate Autism Spectrum Disorder.
Bozaoglu K; Gao Y; Stanley E; Fanjul-Fernández M; Brown NJ; Pope K; Green CC; Vlahos K; Sourris K; Bahlo M; Delatycki M; Scheffer I; Lockhart PJ
Stem Cell Res; 2019 Aug; 39():101516. PubMed ID: 31415975
[TBL] [Abstract][Full Text] [Related]
52. Generation of a human induced pluripotent stem cell (iPSC) line carrying the Parkinson's disease linked LRRK2 variant S1647T.
Ma D; Ng SH; Zeng L; Zhao Y; Tan EK
Stem Cell Res; 2017 Jan; 18():54-56. PubMed ID: 28395805
[TBL] [Abstract][Full Text] [Related]
53. Characterization of human induced pluripotent stem cells line JLUEYEi002-A from a 48 year old healthy male.
Wu H; Cheng Y; Lv Z; Liu L; Gong W; Zhang S
Stem Cell Res; 2021 May; 53():102221. PubMed ID: 33677395
[TBL] [Abstract][Full Text] [Related]
54. Generation of an integration-free induced pluripotent stem cell line, FJMUUHi002-A, from a Rett syndrome patient with a heterozygous mutation p. R133C in MeCP2.
Guo Y; Li J; Xie W; Huang H; Li JJ; Lin W; Lu YQ
Stem Cell Res; 2024 Feb; 74():103268. PubMed ID: 38100910
[TBL] [Abstract][Full Text] [Related]
55. Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene.
Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Mar; 27():90-94. PubMed ID: 29353703
[TBL] [Abstract][Full Text] [Related]
56. Establishment of induced pluripotent stem cell (iPSC) line from 55-year old male patient with hemorrhagic Moyamoya disease.
Cardano M; Marsoner F; Marcatili M; Karnavas T; Zasso J; Lanterna LA; Conti L
Stem Cell Res; 2016 Nov; 17(3):623-626. PubMed ID: 27934594
[TBL] [Abstract][Full Text] [Related]
57. Establishment of human induced pluripotent stem cell line SDQLCHi029-A from one Type 1 familial glucocorticoid deficiency patient carrying compound heterozygote mutations in MC2R gene.
Zhang H; Liu C; Liu Y; Gai Z
Stem Cell Res; 2024 Apr; 76():103368. PubMed ID: 38430736
[TBL] [Abstract][Full Text] [Related]
58. Generation of the UAE's first Emirati induced pluripotent stem cell line KUSTi001-A from peripheral blood derived CD34+ hematopoietic cells.
Azzam SK; Alsafar H; Sajini AA
Stem Cell Res; 2022 Aug; 63():102853. PubMed ID: 35816920
[TBL] [Abstract][Full Text] [Related]
59. Generation of human induced pluripotent stem cell lines carrying heterozygous PLN mutation from dilated cardiomyopathy patients.
Caudal A; Mondejar-Parreño G; Vera CD; Williams DR; Shenoy SP; Liang D; Wu JC
Stem Cell Res; 2022 Aug; 63():102855. PubMed ID: 35853412
[TBL] [Abstract][Full Text] [Related]
60. An integration-free iPSC line ZZUNEUi028-A derived from a patient with hypertrophic cardiomyopathy carrying a heterozygous mutation (c. 1504 C > T) in MYBPC3 gene.
Cheng D; Zhang S; Li X; Wang L; Dong J; Sang H
Stem Cell Res; 2022 Aug; 63():102848. PubMed ID: 35772297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
